[Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
The treatment of chronic obstructive respiratory diseases with sustained release theophylline is steadily gaining in importance. Body plethysmography is applied for evaluating the extent of bronchospasmolysis during therapy of a new sustained release formula. A traditional prolonged-action theophylline-ethylenediamine preparation was administered to obtain comparative data. The sustained release formula containing pure theophylline meets the standards of a modern theophylline therapy. The graduation of the film tablet allows individualized dosage without losing the sustained release action by slowly increasing the theophylline-serum-level during a dosage interval of 12 hours.